Chutko L S, Surushkina S Yu, Yakovenko E A, Kropotov Yu D, Sergeev A V
Bekhterev Institute of Human Brain Russian Academy of Sciences, St. Petersburg, Russia.
Zh Nevrol Psikhiatr Im S S Korsakova. 2017;117(5):9-13. doi: 10.17116/jnevro2017117519-13.
To qualify cognitive impairment in adults with attention deficit hyperactivity disorder (ADHD) and evaluate the efficacy of memoplant in the treatment of this pathology.
The authors present the results of the clinical, psychological and electroencephalographic examination of 40 patients with ADHD, aged from 18 to 45 years. All patients received memoplant in dose of 240 mg a day for 8 weeks.
Adult patients with ADHD were characterized by both subjective and objective disorders of memory and attention. The results of the electroencephalographic study suggested the dysfunction of the frontal-thalamic regulatory system and the lack of non-specific activation of the reticular formation. After treatment, clinical improvement was observed in 24 patients (60.0%). Repeated psychological and neuropsychological examinations showed a reduction of inattention and improvement of memory performance.
鉴定成人注意力缺陷多动障碍（ADHD）患者的认知障碍，并评估美金刚治疗该病症的疗效。
作者呈现了40例年龄在18至45岁的ADHD患者的临床、心理和脑电图检查结果。所有患者均接受每日240毫克的美金刚治疗，为期8周。
成年ADHD患者存在主观和客观的记忆与注意力障碍。脑电图研究结果提示额叶 - 丘脑调节系统功能障碍以及网状结构缺乏非特异性激活。治疗后，24例患者（60.0%）出现临床改善。重复的心理和神经心理学检查显示注意力不集中症状减轻，记忆表现改善。
